Validation of a simple body map to measure widespread pain in urologic chronic pelvic pain syndrome: A MAPP research network study

J Quentin Clemens; Kenneth Locke Jr; J Richard Landis; Karl Kreder; Larissa V Rodriguez; Claire C Yang; Frank F Tu; Steven E Harte; Andrew Schrepf; John T Farrar; Siobhan Sutcliffe; Bruce D Naliboff; David A Williams; Niloofar Afari; Theresa Spitznagle; Bayley J Taple; H Henry Lai; Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network

doi:10.1002/nau.25400

Back

Validation of a simple body map to measure widespread pain in urologic chronic pelvic pain syndrome: A MAPP research network study

Journal article

Open access

Peer reviewed

Validation of a simple body map to measure widespread pain in urologic chronic pelvic pain syndrome: A MAPP research network study

J Quentin Clemens, Kenneth Locke Jr, J Richard Landis, Karl Kreder, Larissa V Rodriguez, Claire C Yang, Frank F Tu, Steven E Harte, Andrew Schrepf, John T Farrar, …

Neurourology and urodynamics, Vol.43(3), pp.727-737

03/2024

DOI: 10.1002/nau.25400

PMCID: PMC10981467

PMID: 38270336

Files and links (1)

url

https://doi.org/10.1002/nau.25400View

Published (Version of record) Open Access

Abstract

In patients with urologic chronic pelvic pain syndrome (UCPPS), the presence of widespread pain appears to identify a distinct phenotype, with a different symptom trajectory and potentially different response to treatment than patients with pelvic pain only. A 76-site body map was administered four times, at weekly intervals, to 568 male and female UCPPS participants in the MAPP Network protocol. The 76 sites were classified into 13 regions (1 pelvic region and 12 nonpelvic regions). The degree of widespread pain was scored from 0 to 12 based on the number of reported nonpelvic pain regions. This continuous body map score was regressed over other measures of widespread pain, with UCPPS symptom severity, and with psychosocial variables to measure level of association. These models were repeated using an updated body map score (0-12) that incorporated a threshold of pain ≥ 4 at each site. Body map scores showed limited variability over the 4 weekly assessments, indicating that a single baseline assessment was sufficient. The widespread pain score correlated highly with other measures of widespread pain and correlated with worsened UCPPS symptom severity and psychosocial functioning. Incorporating a pain severity threshold ≥4 resulted in only marginal increases in these correlations. These results support the use of this 13-region body map in the baseline clinical assessment of UCPPS patients. It provides reliable data about the presence of widespread pain and does not require measurement of pain severity, making it relatively simple to use for clinical purposes.

prostate

pelvic pain

interstitial cystitis/bladder pain syndrome

urinary bladder

chronic prostatitis/chronic pelvic pain syndrome

Details

Title: Subtitle: Validation of a simple body map to measure widespread pain in urologic chronic pelvic pain syndrome: A MAPP research network study
Creators: J Quentin Clemens - University of Michigan
Kenneth Locke Jr - University of Pennsylvania
J Richard Landis - University of Pennsylvania
Karl Kreder - University of Iowa
Larissa V Rodriguez - Weill Cornell Medicine
Claire C Yang - University of Washington
Frank F Tu - NorthShore University HealthSystem
Steven E Harte - University of Michigan
Andrew Schrepf - University of Michigan
John T Farrar - University of Pennsylvania
Siobhan Sutcliffe - Washington University in St. Louis
Bruce D Naliboff - University of California, Los Angeles
David A Williams - University of Michigan
Niloofar Afari - University of California San Diego
Theresa Spitznagle - Washington University in St. Louis
Bayley J Taple - Northwestern University
H Henry Lai - Washington University in St. Louis
Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network
Resource Type: Journal article
Publication Details: Neurourology and urodynamics, Vol.43(3), pp.727-737
DOI: 10.1002/nau.25400
PMID: 38270336
PMCID: PMC10981467
NLM abbreviation: Neurourol Urodyn
ISSN: 0733-2467
eISSN: 1520-6777
Grant note: NIDDK NIH HHS
Language: English
Electronic publication date: 01/25/2024
Date published: 03/2024
Academic Unit: Obstetrics and Gynecology; Urology
Record Identifier: 9984549557102771

Metrics

8 Record Views

7 Times Cited - Web of Science